At NNMC, a modern non-invasive liver assessment is available using the Mindray Hepatus 6 system.
The device helps assess liver tissue and determine:
🔹 the degree of liver fibrosis
🔹 the presence and severity of steatosis — fatty changes in the liver
🔹 changes over time during follow-up examinations
One of the key advantages of Mindray Hepatus 6 is the ability to assess liver health non-invasively, without the need for a liver biopsy.
The examination may be particularly relevant if:
✔️ ALT, AST, or GGT levels are elevated
✔️ fatty liver changes have been detected on ultrasound
✔️ you are overweight or have obesity
✔️ you have been diagnosed with diabetes
✔️ you have viral hepatitis
✔️ you have other chronic liver diseases
It is important to understand that fatty liver changes are not always a harmless finding. In some patients, fibrosis may develop and progress over time, which is why timely assessment of liver tissue is important.
Mindray Hepatus 6 provides additional information about liver health and helps monitor changes over time.
Based on the examination results, a doctor can assess the condition of the liver and determine the appropriate follow-up or treatment strategy.
📲 WhatsApp: +7 700 599-91-03
☎️ +7 (7172) 57-74-40 | +7 708 987-74-40
📍 42 Abylai Khan Avenue, Astana
